FeesSafety
Pluang+

SIGA secures up to $15M contract to supply smallpox antiviral TPOXX to Canadian Defence.

Market News
28 Oct 2026, 14:30 WIB
GlobeNewsWire
View Source
Bullish
SIGA secures up to $15M contract to supply smallpox antiviral TPOXX to Canadian Defence.

SIGA Technologies has been awarded a contract by the Canadian Department of National Defence to supply oral TPOXX, an antiviral for smallpox, valued at up to $15 million through March 2031. This contract continues Canada's commitment to smallpox preparedness and ensures the Canadian Armed Forces have access to approved medical countermeasures. The deal includes $9 million in firm commitments for the first three years and an additional $6 million in options. SIGA highlights the importance of readiness for public health emergencies and aims to strengthen global partnerships in infectious disease protection.

SIGA Technologies' contract with the Canadian Department of National Defence provides context for the health sector. For readers following health stocks, here is Pluang's market snapshot as of Oct 28, 2026 17:41 WIB: out of 150 priced US health stocks, 42 rose and 94 fell. Notable movers include AXGN at USD 43.50 with a 16.12% increase and 100% sell order activity, and NUWE at USD 4.75 with a 12.68% decrease and also 100% sell order activity.

More News

Goldman Sachs forecasts S&P 500 to rise 26% to 8,700 by late 2027 amid tech stock value rebound.

Goldman Sachs forecasts S&P 500 to rise 26% to 8,700 by late 2027 amid tech stock value rebound.

Goldman Sachs predicts the S&P 500 will climb about 26% to 8,700 points within the next 12 months, despite recent market volatility and concerns over AI-driven tech investments. The forecast is supported by lower valuations in tech stocks and a forwa...

Bullish
1 hour ago
S&P 500 nearly quadrupled investments in 10 years despite recent pullbacks, driven by rising corporate profits.

S&P 500 nearly quadrupled investments in 10 years despite recent pullbacks, driven by rising corporate profits.

Over the past decade, the S&P 500 index has risen 229%, turning a $1,000 investment into nearly $4,000, mainly due to a 212% increase in corporate earnings rather than valuation changes. Despite recent market drops and volatility, holding through pul...

Bullish
1 hour ago
Bristol Myers Squibb offers a 4.3% yield with strong new drug growth despite upcoming patent risks.

Bristol Myers Squibb offers a 4.3% yield with strong new drug growth despite upcoming patent risks.

Bristol Myers Squibb, a major pharmaceutical company, currently offers a 4.3% dividend yield and trades at a price-to-earnings ratio well below the industry average. Its newer drug portfolio generated nearly $7.7 billion in revenue last quarter, grow...

Market News
Bullish
1 hour ago
Nvidia stock plunges 43% after CEO Jensen Huang resigns amid scandal, but analyst sees 65% upside ahead.

Nvidia stock plunges 43% after CEO Jensen Huang resigns amid scandal, but analyst sees 65% upside ahead.

Nvidia's stock has dropped about 43% following CEO Jensen Huang's sudden resignation linked to alleged Chinese intelligence ties, wiping out over $2.5 trillion in market value. Despite concerns about leadership loss, analyst Dan Ives believes Nvidia'...

Market News
Bearish
1 hour ago
ASUS launches holiday sale with up to 44% off laptops and desktops until Dec 2, 2026

ASUS launches holiday sale with up to 44% off laptops and desktops until Dec 2, 2026

ASUS has announced a holiday sale offering discounts up to 44% on a wide range of laptops and desktops, available online and in stores like Best Buy until December 2, 2026. The sale features budget-friendly options like the ASUS Vivobook 14 starting ...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App